{
    "organizations": [],
    "uuid": "33574c6e3db5e4b864f0bcae5013c56b757bedd2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-lodo-therapeutics-has-formed-a-str/brief-lodo-therapeutics-has-formed-a-strategic-drug-discovery-collaboration-with-genentech-idUSFWN1SG168",
    "ord_in_thread": 0,
    "title": "BRIEF-Lodo Therapeutics - Has Formed A Strategic Drug Discovery Collaboration With Genentech",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Roche Holding AG:\n* LODO THERAPEUTICS - HAS FORMED A STRATEGIC DRUG DISCOVERY COLLABORATION WITH GENENTECH, A MEMBER OF ROCHE GROUP\n* LODO THERAPEUTICS - UNDER AGREEMENT, GENENTECH WILL UTILIZE COâ€™S PROPRIETARY GENOME MINING AND BIOSYNTHETIC CLUSTER ASSEMBLY PLATFORM\n* LODO THERAPEUTICS - WILL RECEIVE UNDISCLOSED UPFRONT PAYMENT, ELIGIBLE TO RECEIVE MILESTONE PAYMENTS UP TO $969 MILLION FROM DEAL\n* LODO THERAPEUTICS - IS ELIGIBLE TO RECEIVE TIERED-ROYALTIES ON SALES OF CERTAIN PRODUCTS RESULTING FROM COLLABORATION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-09T20:12:00.000+03:00",
    "crawled": "2018-05-10T17:28:27.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "roche",
        "holding",
        "ag",
        "lodo",
        "therapeutic",
        "formed",
        "strategic",
        "drug",
        "discovery",
        "collaboration",
        "genentech",
        "member",
        "roche",
        "group",
        "lodo",
        "therapeutic",
        "agreement",
        "genentech",
        "utilize",
        "co",
        "proprietary",
        "genome",
        "mining",
        "biosynthetic",
        "cluster",
        "assembly",
        "platform",
        "lodo",
        "therapeutic",
        "receive",
        "undisclosed",
        "upfront",
        "payment",
        "eligible",
        "receive",
        "milestone",
        "payment",
        "million",
        "deal",
        "lodo",
        "therapeutic",
        "eligible",
        "receive",
        "sale",
        "certain",
        "product",
        "resulting",
        "collaboration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}